211 related articles for article (PubMed ID: 29484372)
1. Sphingosine kinase inhibitors: A patent review.
Cao M; Ji C; Zhou Y; Huang W; Ni W; Tong X; Wei JF
Int J Mol Med; 2018 May; 41(5):2450-2460. PubMed ID: 29484372
[TBL] [Abstract][Full Text] [Related]
2. Drugging sphingosine kinases.
Santos WL; Lynch KR
ACS Chem Biol; 2015 Jan; 10(1):225-33. PubMed ID: 25384187
[TBL] [Abstract][Full Text] [Related]
3. Importance of sphingosine kinase (SphK) as a target in developing cancer therapeutics and recent developments in the synthesis of novel SphK inhibitors.
Plano D; Amin S; Sharma AK
J Med Chem; 2014 Jul; 57(13):5509-24. PubMed ID: 24471412
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of sphingosine analogues as inhibitors of sphingosine kinases.
Wong L; Tan SS; Lam Y; Melendez AJ
J Med Chem; 2009 Jun; 52(12):3618-26. PubMed ID: 19469544
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic potential of targeting sphingosine kinases and sphingosine 1-phosphate in hematological malignancies.
Evangelisti C; Evangelisti C; Buontempo F; Lonetti A; Orsini E; Chiarini F; Barata JT; Pyne S; Pyne NJ; Martelli AM
Leukemia; 2016 Nov; 30(11):2142-2151. PubMed ID: 27461062
[TBL] [Abstract][Full Text] [Related]
6. New perspectives on the role of sphingosine 1-phosphate in cancer.
Pyne S; Pyne NJ
Handb Exp Pharmacol; 2013; (216):55-71. PubMed ID: 23563651
[TBL] [Abstract][Full Text] [Related]
7. Development of small-molecule inhibitors of sphingosine-1-phosphate signaling.
Edmonds Y; Milstien S; Spiegel S
Pharmacol Ther; 2011 Dec; 132(3):352-60. PubMed ID: 21906625
[TBL] [Abstract][Full Text] [Related]
8. Sphingosine 1-phosphate and sphingosine kinases in health and disease: Recent advances.
Pyne S; Adams DR; Pyne NJ
Prog Lipid Res; 2016 Apr; 62():93-106. PubMed ID: 26970273
[TBL] [Abstract][Full Text] [Related]
9. "Dicing and Splicing" Sphingosine Kinase and Relevance to Cancer.
Haddadi N; Lin Y; Simpson AM; Nassif NT; McGowan EM
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28869494
[TBL] [Abstract][Full Text] [Related]
10. Sphingosine kinase/sphingosine 1-phosphate signaling in cancer therapeutics and drug resistance.
Selvam SP; Ogretmen B
Handb Exp Pharmacol; 2013; (216):3-27. PubMed ID: 23563649
[TBL] [Abstract][Full Text] [Related]
11. Sphingosine kinase signalling in immune cells: potential as novel therapeutic targets.
Melendez AJ
Biochim Biophys Acta; 2008 Jan; 1784(1):66-75. PubMed ID: 17913601
[TBL] [Abstract][Full Text] [Related]
12. Mammalian sphingosine kinase (SphK) isoenzymes and isoform expression: challenges for SphK as an oncotarget.
Hatoum D; Haddadi N; Lin Y; Nassif NT; McGowan EM
Oncotarget; 2017 May; 8(22):36898-36929. PubMed ID: 28415564
[TBL] [Abstract][Full Text] [Related]
13. Sphingosine-1-phosphate: the Swiss army knife of sphingolipid signaling.
Maceyka M; Milstien S; Spiegel S
J Lipid Res; 2009 Apr; 50 Suppl(Suppl):S272-6. PubMed ID: 18987387
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationship studies and in vivo activity of guanidine-based sphingosine kinase inhibitors: discovery of SphK1- and SphK2-selective inhibitors.
Patwardhan NN; Morris EA; Kharel Y; Raje MR; Gao M; Tomsig JL; Lynch KR; Santos WL
J Med Chem; 2015 Feb; 58(4):1879-1899. PubMed ID: 25643074
[TBL] [Abstract][Full Text] [Related]
15. Metastatic triple-negative breast cancer is dependent on SphKs/S1P signaling for growth and survival.
Maiti A; Takabe K; Hait NC
Cell Signal; 2017 Apr; 32():85-92. PubMed ID: 28108260
[TBL] [Abstract][Full Text] [Related]
16. Targeting the sphingosine kinase/sphingosine 1-phosphate pathway in disease: review of sphingosine kinase inhibitors.
Orr Gandy KA; Obeid LM
Biochim Biophys Acta; 2013 Jan; 1831(1):157-66. PubMed ID: 22801037
[TBL] [Abstract][Full Text] [Related]
17. Building a better sphingosine kinase-1 inhibitor.
Lynch KR
Biochem J; 2012 May; 444(1):e1-2. PubMed ID: 22533672
[TBL] [Abstract][Full Text] [Related]
18. A rapid assay for assessment of sphingosine kinase inhibitors and substrates.
Kharel Y; Mathews TP; Kennedy AJ; Houck JD; Macdonald TL; Lynch KR
Anal Biochem; 2011 Apr; 411(2):230-5. PubMed ID: 21216217
[TBL] [Abstract][Full Text] [Related]
19. Activation of the SPHK/S1P signalling pathway is coupled to muscarinic receptor-dependent regulation of peripheral airways.
Pfaff M; Powaga N; Akinci S; Schütz W; Banno Y; Wiegand S; Kummer W; Wess J; Haberberger RV
Respir Res; 2005 May; 6(1):48. PubMed ID: 15927078
[TBL] [Abstract][Full Text] [Related]
20. Sphingosine kinase inhibitors: a review of patent literature (2006-2015).
Lynch KR; Thorpe SB; Santos WL
Expert Opin Ther Pat; 2016 Dec; 26(12):1409-1416. PubMed ID: 27539678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
